China Pharma Holding (STU:XQJ0) COGS-to-Revenue : 1.21 (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is China Pharma Holding COGS-to-Revenue?

China Pharma Holding's Cost of Goods Sold for the three months ended in Mar. 2024 was €1.53 Mil. Its Revenue for the three months ended in Mar. 2024 was €1.26 Mil.

China Pharma Holding's COGS to Revenue for the three months ended in Mar. 2024 was 1.21.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. China Pharma Holding's Gross Margin % for the three months ended in Mar. 2024 was -21.19%.

China Pharma Holding COGS-to-Revenue Historical Data

The historical data trend for China Pharma Holding's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Pharma Holding COGS-to-Revenue Chart

China Pharma Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.86

0.82

0.96

1.06

1.04

China Pharma Holding Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.91	1.13	1.13	1.04	1.21

China Pharma Holding COGS-to-Revenue Calculation

China Pharma Holding's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	6.687	/	6.429
	=	1.04

China Pharma Holding's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.527	/	1.26
	=	1.21

China Pharma Holding (STU:XQJ0) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

China Pharma Holding's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1.527 / 1.26
	=	-21.19 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

China Pharma Holding COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Pharma Holding's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

China Pharma Holding (STU:XQJ0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Pharma Holding Inc (STU:XQJ0) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

CPHI:USA

Address

Second Floor, No. 17, Jinpan Road, Hainan Province, Haikou, CHN, 570216

Website

https://www.chinapharmaholdings.com

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.

China Pharma Holding (STU:XQJ0) Headlines

No Headlines